| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 355 |
| 1 | DEXAMETHASONE 1.5 MG | 355 |
| 2 | CYCLOPHOSPHAMIDE | 339 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 339 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 339 |
| 5 | LENALIDOMIDE | 309 |
| 6 | BORTEZOMIB | 288 |
| 7 | ETOPOSIDE | 251 |
| 8 | VENETOCLAX | 249 |
| 9 | DARATUMUMAB | 195 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROSUVSTATIN | 1 | 0.1000 |
| 1 | UNDECYLENIC ACID | 4 | 0.0288 |
| 2 | PALIFERMIN | 8 | 0.0206 |
| 3 | ISATUXIMAB-IRFC | 1 | 0.0185 |
| 4 | IBRITUMOMAB TIUXETAN | 27 | 0.0177 |
| 5 | TOLNAFTATE 1% | 4 | 0.0138 |
| 6 | PONATINIB HYDROCHLORIDE | 60 | 0.0115 |
| 7 | CARMUSTINE | 54 | 0.0114 |
| 8 | OLUTASIDENIB | 3 | 0.0104 |
| 9 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 568 |
| 1 | Alkylating Drug [EPC] | 455 |
| 2 | Thalidomide Analog [EPC] | 312 |
| 3 | Proteasome Inhibitor [EPC] | 305 |
| 4 | Topoisomerase Inhibitor [EPC] | 251 |
| 5 | BCL-2 Inhibitor [EPC] | 249 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 217 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 215 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 177 |
| 9 | Kinase Inhibitor [EPC] | 167 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 215 | 0.0367 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 8 | 0.0206 |
| 2 | Endoglycosidase [EPC] | 18 | 0.0097 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 18 | 0.0055 |
| 4 | Hematopoietic Stem Cell Mobilizer [EPC] | 6 | 0.0040 |
| 5 | BCL-2 Inhibitor [EPC] | 249 | 0.0040 |
| 6 | Topoisomerase Inhibitor [EPC] | 251 | 0.0033 |
| 7 | Interferon gamma [EPC] | 4 | 0.0028 |
| 8 | CD33-directed Immunoconjugate [EPC] | 10 | 0.0027 |
| 9 | Proteasome Inhibitor [EPC] | 305 | 0.0027 |